Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
non-small cell lung cancer
Biotech
AstraZeneca-Daiichi get some clarity on Enhertu follow up med
Daiichi Sankyo and AstraZeneca finally have some clarity on the deaths that occurred in two phase 3 studies for their Enhertu follow up Dato-DXd.
Annalee Armstrong
Oct 23, 2023 10:30am
BioNTech pays $70M for HER3-directed rival to Daiichi ADC
Oct 12, 2023 8:30am
Kinnate lays off 70% of staff, pulls back from programs
Sep 19, 2023 6:00am
AstraZeneca, Daiichi show off ADCs with safety top of mind
Sep 11, 2023 9:58am
Roche's KRAS data suggest potential edge over Amgen and Mirati
Aug 24, 2023 10:25am
Roche posts TIGIT survival data after 'inadvertent disclosure'
Aug 23, 2023 5:36am
